View cart “Babystart¨ FertilTestsª Fertility test for Couples” has been added to your cart.

FertilOva™ dietary supplement

£17.99

FertilOva™ is a dietary supplement formulated for reproductive health.

FertilOva™ supports women who may be having difficulty conceiving, as it can help promote regular ovarian function, support regular menstrual cycles and may help increase egg quality. FertilOva™ is especially beneficial to women suffering with Polycystic ovary syndrome (PCOS)

Category:

Description

FertilOva™ is a dietary supplement formulated for reproductive health. FertilOva™ supports women who may be having difficulty conceiving, as it can help promote regular ovarian function, support regular menstrual cycles and may help increase egg quality. FertilOva™ is especially beneficial to women suffering with Polycystic ovary syndrome (PCOS) FertilOva™ has a variety of roles in PCOS, spanning fertility (2,3,4,5) and IVF (1,6,7,8).  FertilOva™ can help to correct menstrual cycle disturbances (9), assist PCOS patients to achieve ovulation consistently (9) and Myo-Inositol is associated with improved oocyte and embryo quality in those patients undergoing assisted reproductive technologies (ART), such as IVF (1,6,7,8). Myo-inositol, the main ingredient in FertilOva™, is present in every living cell and has many important functions. One important role is being part of the ‘second messenger’ system for Insulin (1). Myo-inositol is involved in the signal of insulin from the insulin receptor – particularly important for patients with insulin resistance. It also promotes normal hormone levels, which in turn promotes regular menstrual cycles and normal ovulatory function. Folic acid, the other ingredient in FertilOva™ is a water-soluble vitamin belonging to the B-group vitamins Folic acid plays a key role in the metabolism of amino acids in the protein and fusion and recovery of chromosomes and therefore is a key factor for normal cell division and tissue growth. Research shows that taking Inositol helps to improve the function of the ovaries and metabolic disorders associated with Syndrome polycystic ovaries. Between 65- 80% of patients with PCOS have insulin resistance, where the response to insulin is sub-optimal.  This condition is thought to contribute to a number of other issues related to PCOS, such as metabolic syndrome, hormonal imbalance, androgenic symptoms and diabetes in pregnancy. PCOS patients have a higher risk than normal of developing the metabolic syndrome; a mix of conditions including weight gain, type 2 diabetes and dyslipidaemia.  Approximately one third to one half of all women and adolescent girls with PCOS have the metabolic syndrome.  A recent RCOG ‘green top’ guideline advises doctors to inform patients with PCOS of such long-term health consequences.  Such patients have considerable long-term health risks and the evidence for using FertilOva™ in these patients is compelling.

Additional information

Weight 114.0 kg

Reviews

There are no reviews yet.

Be the first to review “FertilOva™ dietary supplement”